Skip to main content
. 2015 Dec 30;2015(12):CD007394. doi: 10.1002/14651858.CD007394.pub2

Kallel 2003.

Study characteristics
Patient sampling Prospective; series of patients with same risk profile
Not reported whether enrollment was consecutive
Patient characteristics and setting 74 participants
 Age ranged from 8 to 47 years
 No information about gender
 Tunisia
Children and adults who were neutropenic; predominantly allograft patients
 Inpatients, monitoring clinical course
Representative spectrum? Yes: children and adults that were neutropenic; predominantly allograft patients
 Prospective, consecutive patient series
Index tests Platelia. Sera were monitored weekly on Mondays and Tuesdays. Both days positive = positive. All other results = negative. Cut‐off 1.5 ODI
Target condition and reference standard(s) Invasive aspergillosis, as defined by EORTC criteria (Ascioglu 2002)
Incorporation avoided? No: a positive galactomannan test was one of the requirements for probable IA
Flow and timing Not reported
Partial verification avoided? Yes: all patients were classified according to reference criteria
 Withdrawals explained? No
 Uninterpretable results reported? No
Comparative  
No patients per category 1 proven, 4 probable, 2 possible, 67 no
Notes Sponsoring precluded? Unclear: nothing reported about financial support
French
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear    
Was a case‐control design avoided? Yes    
Did the study avoid inappropriate exclusions? Unclear    
    Unclear Low
DOMAIN 2: Index Test All tests
Were the index test results interpreted without knowledge of the results of the reference standard? Unclear    
If a threshold was used, was it pre‐specified? Yes    
    Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? No    
    High Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Unclear    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Unclear    
    Unclear